Searched for
CLARIS INJECTABLES
Claris completes sale of global injectables biz to BaxterThe company said it will now discuss with its advisors and identify the most efficient method of transferring a significant majority of the...- Claris-Baxter deal may be good news for investorsAnalysts said the company is likely to a sizeable one-time dividend or share buyback at higher levels.
- Claris Life hits record high but pares most gains over regulatory concernsAnalyst who ET spoke to said the management expressed confidence that an escalation would not happen.
- Baxter to acquire Claris Injectables for Rs 4,237 crore"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- Claris Life gets USFDA nod for generic anesthetic injectionThe injection is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedur...
- Claris gets USFDA nod for anti-bacterial infections injectionWith this approval, the company has a total of 14 approvals and 24 under approval ANDAs and is expecting more product approvals during the ...
- Claris Lifesciences revives talks to sell injectables businessSources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst other...
- Claris Lifesciences gets nod to resume supply of Furosemide injection in USClaris Lifesciences said it has received prior approval supplement (PAS) for Furosemide injection which will help it to resume supply in th...
- Income-Tax Dept searches 20 premises of Claris LifesciencesIncome-Tax sleuths today conducted search and survey operations at around 20 commercial and residential premises of Claris Lifesciences, it...
- Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...
- Claris gets USFDA supplemental nod for Fluconazole injectionThe drug firm said it markets its products through a wholly-owned subsidiary Claris Lifesciences Inc.
- Big pharma eyes takeover of Claris’ injectables business for Rs 2500-Rs 3000 croreCarlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.
- Claris Lifesciences completes transfer of Speciality Injectable BusinessShareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...
- Claris Lifesciences gets Medicines and Healthcare products Regulatory Agency's nod for new plant"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Claris receives MHRA approval for Ahmedabad unitClaris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.
- The needle of life for Claris LifesciencesClaris Lifesciences’ niche lies in developing cheap injectibles.
Load More
